Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / June / Parkinson’s Impact on Corneal Nerves
Cornea Research & Innovations

Parkinson’s Impact on Corneal Nerves

Corneal nerve imaging offers potential non-invasive biomarker for differentiating between motor subtypes of Parkinson’s disease

By The Ophthalmologist 6/25/2025 3 min read

Share

0625-012-AI-News-Parkinsons-Impact-on-Corneal-Nerves.png

Credit: Unsplash.com

In a recent IOVS study, researchers from the First Affiliated Hospital of Harbin Medical University, China, have demonstrated that corneal nerve imaging via in vivo confocal microscopy (IVCM) can differentiate motor subtypes of Parkinson’s disease (PD) – a development with significant implications for early diagnosis and prognosis.

The study involved 63 PD patients and 31 age- and gender-matched controls. PD participants were classified into tremor-dominant (TD), postural instability and gait disturbance (PIGD), and mixed subtypes. Using IVCM, the researchers analyzed central and inferior whorl-like corneal nerve parameters – areas that are rich in small sensory fibers and notably vulnerable in neurodegenerative diseases.

Compared to the healthy controls, PD patients showed significant reductions in several corneal nerve metrics, including corneal nerve fiber length (CNFL), area (CNFA), width (CNFW), and fractal dimension (CNFrD), along with inferior whorl (IWL)-specific indicators. Notably, PIGD patients displayed the most pronounced deficits.

The study also found that reductions in CNFA and CNFrD correlated with higher MDS Unified Parkinson's Disease Rating Scale (MDS-UPDRS) III scores and lower Montreal Cognitive Assessment (MoCA) scores, linking corneal nerve changes to both motor and cognitive dysfunction. PD patients in the study also exhibited decreased corneal sensitivity, tear production (Schirmer I), and tear film stability (TBUT), reinforcing the ophthalmic impact of PD.

The research indicates that IVCM could become a valuable tool in the neurologist’s and ophthalmologist’s arsenal, providing early, non-invasive insights into PD subtype, severity, and progression. While longitudinal studies are needed to confirm temporal changes and treatment effects, this method holds promise for both clinical stratification and research monitoring of Parkinsonian neuropathology.

About the Author(s)

The Ophthalmologist

More Articles by The Ophthalmologist

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: